Cell Publication Highlights Ionpath MIBI Spatial Proteomics Technology in Foundational Study Predicting Breast Cancer Progression
Innovative study deployed multiplexed ion beam imaging (MIBI™) technology revealing a high-multiplex spatial proteomic signature as a predictive biomarker for breast cancer treatment MENLO PARK, Calif.--(BUSINESS WIRE)--#cancer--Ionpath, Inc., the leader ...